RxDoctor Payments Data

Stavros Stavropoulos, MD

Gastroenterology · Bellmore, NYNPI 1679657019

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (43.1%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Boston Scientific at 37.1% of the total. Among gastroenterology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$101,973in general payments, 2019–2025

Across 199 payments — averaging $512.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$38K
  • Lumendi LLC$19K
  • Olympus America Inc.$14K
  • Olympus Corporation Of The Americas$11K
  • Olympus Medical Systems Corporation$6K
  • ERBE USA Inc$5K
  • plus $9K from 14 others
$35,625in research payments, 2019–2025

Across 1 payment — averaging $35,625 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Lumendi LLC$36K

What the payments were for

  • Consulting fees$43,97843%
  • Speaking & faculty fees$28,97828%
  • Travel & lodging$17,07517%
  • Food & beverage$8,2538%
  • Education$3,6904%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$101,973 in reported general payments places this provider in the 95th percentile of 1,682 gastroenterology providers in New York.

See all gastroenterology providers in New York →

Medicare billing

Part B allowed, 2024
$29,722
Medicare patients
64
Services billed
117

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gastroenterology in Bellmore

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →